Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic hepatitis B vaccine 60 μg in HBeAg-positive chronic hepatitis B
CTR20132849Phase 3Active
- Sponsor
- Beijing Institute of Biological Products
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by Beijing Institute of Biological Products. Started May 2014; status: active.
02
Drugs
Hepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20132849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132849.